Symphalangism with multiple anomalies of hands and feet
diseaseOn this page
Also known as Learman syndrome
Summary
Symphalangism with multiple anomalies of hands and feet (MONDO:0008510) is a disease. A subtype of symphalangism — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
- Phenotypes (HPO): 22
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Cases/families | 6 | Worldwide | Validated | |
| Point prevalence | <1 / 1 000 000 | Worldwide | Validated |
Signs & symptoms
Clinical features (HPO)
22 HPO clinical features (Orphanet curated; top 22 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0004197 | Symphalangism of the 4th finger | Very frequent (80-99%) |
| HP:0004218 | Symphalangism of the 5th finger | Very frequent (80-99%) |
| HP:0006019 | Reduced proximal interphalangeal joint space | Very frequent (80-99%) |
| HP:0000256 | Macrocephaly | Frequent (30-79%) |
| HP:0001032 | Absent distal interphalangeal creases | Frequent (30-79%) |
| HP:0001156 | Brachydactyly | Frequent (30-79%) |
| HP:0001245 | Small thenar eminence | Frequent (30-79%) |
| HP:0001770 | Toe syndactyly | Frequent (30-79%) |
| HP:0005807 | Absent distal phalanges | Frequent (30-79%) |
| HP:0006101 | Finger syndactyly | Frequent (30-79%) |
| HP:0007477 | Abnormal dermatoglyphics | Frequent (30-79%) |
| HP:0009700 | Finger symphalangism | Frequent (30-79%) |
| HP:0010179 | Symphalangism affecting the phalanges of the toes | Frequent (30-79%) |
| HP:0010182 | Abnormality of the distal phalanges of the toes | Frequent (30-79%) |
| HP:0010487 | Small hypothenar eminence | Frequent (30-79%) |
| HP:0030084 | Clinodactyly | Frequent (30-79%) |
| HP:0000405 | Conductive hearing impairment | Occasional (5-29%) |
| HP:0001018 | Abnormal palmar dermatoglyphics | Occasional (5-29%) |
| HP:0005650 | 2-5 finger cutaneous syndactyly | Occasional (5-29%) |
| HP:0006143 | Abnormal finger flexion creases | Occasional (5-29%) |
| HP:0010103 | Short distal phalanx of hallux | Occasional (5-29%) |
| HP:0100371 | Aplasia/Hypoplasia of the distal phalanx of the 5th toe | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | symphalangism with multiple anomalies of hands and feet |
| Mondo ID | MONDO:0008510 |
| MeSH | C566098 |
| OMIM | 185750 |
| Orphanet | 3246 |
| SNOMED CT | 732955001 |
| UMLS | C1861391 |
| MedGen | 348859 |
| GARD | 0005077 |
| Is cancer (heuristic) | no |
Also known as: Learman syndrome · symphalangism with multiple anomalies of hands and feet
Disease family
Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › skeletal system disorder › symphalangism › symphalangism with multiple anomalies of hands and feet
Related subtypes (5): symphalangism of toes, symphalangism, C. S. Lewis type, distal symphalangism, proximal symphalangism, NOG-related symphalangism spectrum disorder
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.